|Articles|April 28, 2023
Supplements and Featured Publications
- Managed Care Considerations in the Management of CKD Associated With T2D
Managed Care Considerations in the Management of CKD Associated With T2D
Advertisement
This publication was paid for by and developed under the direction of Bayer. It was not peer reviewed. Financial support and promotional content direction were provided by members of Bayer Market Access team.
This AJMC® Clinical Brief describes ways in which payers can optimize management of patients with chronic kidney disease associated with type 2 diabetes.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer
3
Innovation Is Outpacing Reimbursement, Health System Execs Warn
4
FTC Reaches Settlement With CVS Caremark to Curb Insulin Rebate Practices, Cut Patient Costs
5